FRANTZ VICTOR,MICHAEL JOHN RODRIGUEZ,KARIN BRINER,MATTHEW ROBERT REINHARD,ROGER RYAN ROTHHAAR,MICHAEL PHILIP COHEN,DEYI ZHANG,AJAY SINGH,JOHN GORDON ALLEN,MARIA ANGELES MARTINEZ-GRAU,ANDREW CAERWYN WI
申请号：
PT05723397
公开号：
PT1720836E
申请日:
2005.02.18
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: where: R 6 is -S-L-R 15 and other substituents are as defined in the specification.
